These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says. Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X Front Immunol; 2021; 12():669010. PubMed ID: 34093567 [TBL] [Abstract][Full Text] [Related]
13. Localized cutaneous reaction to an mRNA COVID-19 vaccine. Edriss M; Farshchian M; Daveluy S J Cosmet Dermatol; 2021 Aug; 20(8):2380-2381. PubMed ID: 34129749 [No Abstract] [Full Text] [Related]
14. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Skowronski DM; De Serres G N Engl J Med; 2021 Apr; 384(16):1576-1577. PubMed ID: 33596348 [No Abstract] [Full Text] [Related]
15. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply. Absalon J; Koury K; Gruber WC N Engl J Med; 2021 Apr; 384(16):1578. PubMed ID: 33596351 [No Abstract] [Full Text] [Related]
17. SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning Immunization System. Weitzman ER; Sherman AC; Levy O Front Public Health; 2021; 9():695807. PubMed ID: 34336774 [TBL] [Abstract][Full Text] [Related]
18. In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose. Chagla Z Ann Intern Med; 2021 Mar; 174(3):JC28. PubMed ID: 33646836 [TBL] [Abstract][Full Text] [Related]
19. On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Sun H N Engl J Med; 2021 Oct; 385(16):1535-1536. PubMed ID: 34496197 [No Abstract] [Full Text] [Related]
20. The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose. Chagla Z Ann Intern Med; 2021 Feb; 174(2):JC15. PubMed ID: 33524290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]